This content is in French.
A New Immunological Test for Alzheimer’s Disease
25 janvier 2024
The p-tau217 marker is currently considered the most relevant blood biomarker in Alzheimer’s disease. However, the availability of tests remains limited in both research and clinical settings. In this study, researchers evaluated the…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Nicholas J Ashton et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024 Jan 22.
View the sourceOther recent articles
Psychological Therapies for Adults With ADHD: Meaningful Benefits, but Persistent Gaps in Outcomes
14 octobre 2026
Beyond Recovery: How Exercise-Based Cardiac Rehabilitation Improves Outcomes in Coronary Heart Disease
14 octobre 2026
Bowel Endometriosis: From Gastrointestinal Symptoms to Diagnosis and Management
9 octobre 2026